Expert Insights on Management of High-Risk Osteoporosis
Felicia Cosman, MD, and Nancy E. Lane, MD, provide insight into current diagnosis and treatment strategies for postmenopausal osteoporosis.
What are the long-term benefits of SGLT2 inhibitor treatment to discuss with patients when considering SGLT2 inhibitor therapy? READ THEIR RESPONSES »
